Company Search:
Advanced Search
Sponsored Links
Formycon AG Company Snapshot
Formycon AG operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Formycon AG with three other miscellaneous service companies in Europe: Molecular Partners AG of Switzerland (2016 sales of 23.04 million Swiss Francs [US$23.56 million] of which 100% was Biopharmaceuticals), Adocia SAS of France (22.49 million Euro [US$27.46 million] of which 100% was Regenerative Medicine), and Molmed S.P.A. which is based in Italy (19.48 million Euro [US$23.79 million] ).

Sales Analysis. Formycon AG reported sales of 19.66 million Euro (US$24.01 million) for the year ending December of 2016. This represents an increase of 14.6% versus 2015, when the company's sales were 17.15 million Euro. This was the third consecutive year of growth at Formycon AG.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Formycon AG
  Stock Performance Chart for Formycon AG
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 33.00
(Figures in Euro)
1 Week 4.8%   13 Weeks 3.3%  
4 Weeks 2.2%   52 Weeks 26.0%  
Formycon AG Key Data:
  Ticker: FYB Country: Germany
  Exchanges: FRA Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 19,663,676
(Year Ending Jan 2017).
Employees: 16
  Currency: Euro Market Cap: 300,286,899
  Fiscal Yr Ends: December Shares Outstanding: 9,099,603
  Share Type: ORDINARY Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.